88 related articles for article (PubMed ID: 17436599)
21. Differential cardiovascular effects of synthetic peptides derived from endomorphin-1 in anesthetized rats.
Liu H; Yang Y; Xin R; Liu X; Cao Y; Ni J; Wang R
Peptides; 2008 Jun; 29(6):1048-56. PubMed ID: 18433935
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and activity of the melanocortin Xaa-d-Phe-Arg-Trp-NH tetrapeptides with amide bond modifications.
Todorovic A; Holder JR; Scott JW; Haskell-Luevano C
J Pept Res; 2004 Mar; 63(3):270-8. PubMed ID: 15049839
[TBL] [Abstract][Full Text] [Related]
23. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library.
Schmid B; Warnecke A; Fichtner I; Jung M; Kratz F
Bioconjug Chem; 2007; 18(6):1786-99. PubMed ID: 17915955
[TBL] [Abstract][Full Text] [Related]
24. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
[TBL] [Abstract][Full Text] [Related]
25. Enhancing macrocyclic diterpenes as multidrug-resistance reversers: structure-activity studies on jolkinol D derivatives.
Reis M; Ferreira RJ; Santos MM; dos Santos DJ; Molnár J; Ferreira MJ
J Med Chem; 2013 Feb; 56(3):748-60. PubMed ID: 23336337
[TBL] [Abstract][Full Text] [Related]
26. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
27. Screening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulators.
Ivanova A; Serly J; Dinchev D; Ocsovszki I; Kostova I; Molnar J
In Vivo; 2009; 23(4):545-50. PubMed ID: 19567388
[TBL] [Abstract][Full Text] [Related]
28. Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor.
Cao X; Bloomston M; Zhang T; Frankel WL; Jia G; Wang B; Hall NC; Koch RM; Cheng H; Knopp MV; Sun D
Clin Cancer Res; 2008 Mar; 14(6):1831-9. PubMed ID: 18347186
[TBL] [Abstract][Full Text] [Related]
29. Chemoprevention and inhibition of P-glycoprotein in cancer cells by Chinese medicinal herbs.
Engi H; Hohmann J; Gang G; Pusztai R; Rédei D; Kovács O; Schelz Z; Molnár J
Phytother Res; 2008 Dec; 22(12):1671-6. PubMed ID: 18690658
[TBL] [Abstract][Full Text] [Related]
30. Chymase-dependent conversion of Big endothelin-1 in the mouse in vivo.
Simard E; Jin D; Takai S; Miyazaki M; Brochu I; D'Orléans-Juste P
J Pharmacol Exp Ther; 2009 Feb; 328(2):540-8. PubMed ID: 18987301
[TBL] [Abstract][Full Text] [Related]
31. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C
Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and multidrug resistance reversal activity of dihydroptychantol A and its novel derivatives.
Sun B; Yuan HQ; Xi GM; Ma YD; Lou HX
Bioorg Med Chem; 2009 Jul; 17(14):4981-9. PubMed ID: 19540127
[TBL] [Abstract][Full Text] [Related]
33. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of new symmetrical derivatives of dihydropyridine containing a pyridyl group on the 3, 5-positions and evaluation of their cytotoxic and multidrug resistance reversal activity.
Foroughinia F; Javidnia K; Amirghofran Z; Mehdipour A; Miri R
J Pharm Pharmacol; 2008 Nov; 60(11):1481-9. PubMed ID: 18957169
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
[TBL] [Abstract][Full Text] [Related]
36. Surface-enhanced Raman difference between bombesin and its modified analogues on the colloidal and electrochemically roughen silver surfaces.
Podstawka E; Ozaki Y
Biopolymers; 2008 Oct; 89(10):807-19. PubMed ID: 18491414
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.
Wan HX; Zhou C; Zhang Y; Sun M; Wang X; Yu H; Yang X; Ye RD; Shen JK; Wang MW
Biochem Pharmacol; 2007 Jul; 74(2):317-26. PubMed ID: 17517377
[TBL] [Abstract][Full Text] [Related]
38. Novel side-chain glucosylated and adamantylated [Asp(2)/Glu(2)]enkephalin analogs: synthesis and in vitro growth inhibition of human tumor cells.
Horvat S; Kralj M; Perc M; Jerić I; Varga-Defterdarović L; Jakas A; Roscić M; Suman L; Gredicak M
Chem Biol Drug Des; 2009 Feb; 73(2):253-7. PubMed ID: 19207428
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of RNA helicase A by DNA-dependent protein kinase is indispensable for expression of the MDR1 gene product P-glycoprotein in multidrug-resistant human leukemia cells.
Zhong X; Safa AR
Biochemistry; 2007 May; 46(19):5766-75. PubMed ID: 17441731
[TBL] [Abstract][Full Text] [Related]
40. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation.
Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F
Br J Pharmacol; 1997 Jun; 121(4):705-10. PubMed ID: 9208137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
